Compare AMPH & ULCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | ULCC |
|---|---|---|
| Founded | 1996 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2005 | 2017 |
| Metric | AMPH | ULCC |
|---|---|---|
| Price | $28.85 | $7.64 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 7 | 12 |
| Target Price | ★ $24.50 | $7.39 |
| AVG Volume (30 Days) | 415.9K | ★ 4.2M |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.67 | N/A |
| Revenue | $719,887,000.00 | ★ $3,724,000,000.00 |
| Revenue This Year | $3.81 | $33.78 |
| Revenue Next Year | $4.91 | $9.38 |
| P/E Ratio | $17.10 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.65 | $3.02 |
| 52 Week High | $31.00 | $8.53 |
| Indicator | AMPH | ULCC |
|---|---|---|
| Relative Strength Index (RSI) | 64.24 | 62.77 |
| Support Level | $27.24 | $5.42 |
| Resistance Level | $29.35 | $8.36 |
| Average True Range (ATR) | 1.07 | 0.61 |
| MACD | 0.15 | 0.21 |
| Stochastic Oscillator | 61.97 | 77.32 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos, and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. The majority of revenue is from Domestic flight follow by International.